• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    ANI Pharma Inc (NQ: ANIP )

    62.64 -0.80 (-1.26%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 104,907
    Open 63.03
    Bid (Size) 61.15 (1)
    Ask (Size) 65.38 (1)
    Prev. Close 63.44
    Today's Range 62.41 - 63.60
    52wk Range 48.20 - 70.81
    Shares Outstanding 24,422,240
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), PlayAGS, Incorporated (NYSE - AGS), RBAZ Bancorp, Inc. (OTCPK - RBAZ)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga

    Performance

    YTD
    +9.53%
    +9.53%
    1 Month
    -1.26%
    -1.26%
    3 Month
    -6.12%
    -6.12%
    6 Month
    +9.53%
    +9.53%
    1 Year
    +15.96%
    +15.96%

    More News

    Read More
    Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Evaluating ANI Pharmaceuticals: Insights From 5 Financial Analysts
    Via Benzinga
    Expert Outlook: ANI Pharmaceuticals Through The Eyes Of 4 Analysts
    Via Benzinga
    Earnings Scheduled For February 29, 2024
    Via Benzinga
    ANI Pharmaceuticals's Earnings Outlook
    Via Benzinga
    Why Is Alimera Sciences (ALIM) Stock Up 77% Today?
    Via InvestorPlace
    Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
    Via Benzinga
    ANIP Stock Earnings: ANI Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Alphabet, Dover And 2 Other Stocks Insiders Are Selling
    Via Benzinga
    Drug Maker Organon Stock Scores Relative Strength Upgrade
    Via Investor's Business Daily
    Expert Ratings for ANI Pharmaceuticals
    Via Benzinga
    Analyst Expectations for ANI Pharmaceuticals's Future
    Via Benzinga
    What 4 Analyst Ratings Have To Say About ANI Pharmaceuticals
    Via Benzinga
    Where ANI Pharmaceuticals Stands With Analysts
    Via Benzinga
    Truist Securities Maintains Buy Rating for ANI Pharmaceuticals: Here's What You Need To Know
    Via Benzinga
    Why Is Generic Drug Player ANI Pharmaceuticals Stock Trading Lower Today?
    Via Benzinga
    ANI Pharmaceuticals Inc. (NASDAQ: ANIP) Records 52-Week High Wednesday Morning
    Via Investor Brand Network
    7 A-Rated Biotech Stocks for Your August Buy List
    Via InvestorPlace
    Looking Into ANI Pharmaceuticals's Return On Capital Employed
    Via Benzinga
    ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference
    From ANI Pharmaceuticals, Inc.
    Via Business Wire
    ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From ANI Pharmaceuticals, Inc.
    Via Business Wire
    ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity
    From ANI Pharmaceuticals, Inc.
    Via Business Wire
    ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock
    From ANI Pharmaceuticals, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.